Ischemic heart disease — all decisions

The Board granted service connection for the Veteran's death, finding that his coronary artery disease was related to his military service due to exposure to herbicide agents.

The Board denied the veteran's claims for increased ratings for coronary artery disease, diabetes mellitus type II, obstructive sleep apnea syndrome, peripheral neuropathy of both lower extremities, and left ear hearing loss. The veteran was granted a TDIU.

The Board granted service connection for multiple conditions, including a bilateral eye disability and cardiovascular conditions, based on the Veteran's in-service occupational exposures.

The Board denied an effective date earlier than May 26, 2016, for a separate rating for right knee instability and left knee instability. The claims for higher ratings based on limitation of motion and instability of the knees, separate ratings for meniscus conditions of the knees, and secondary service connection claims were remanded.

The Board granted a total disability rating based on individual unemployability (TDIU) effective July 20, 2021, but denied an initial disability rating in excess of 50 percent for obstructive sleep apnea.

The Board denied service connection for hypertension, carotid artery disease, coronary artery disease, and renal artery disease as they were not shown to be chronic in service or manifest within the applicable presumptive period; continuity of symptomatology was not established; and there is no evidence that any of these disabilities are otherwise etiologically related to an in-service injury or disease.

The claim for service connection for valvular heart disease is dismissed as the Veteran was granted a full grant of benefits for coronary artery disease, which is considered a full grant of the benefits sought on appeal.

The Board granted service connection for a heart condition as secondary to the Veteran's service-connected lymphedema and granted an initial 20% rating for a painful and unstable scar on the right mid-shin, effective April 14, 2022. Other claims were remanded.

The Board denied earlier effective dates for the grant of service connection for bilateral upper and lower extremity radiculopathy, remanded claims for increased ratings for knee and spine disabilities, and remanded claims for service connection for coronary artery disease, sleep apnea, and GERD.

The Board granted service connection for chronic lymphocytic leukemia, coronary artery disease with atrial fibrillation, diabetes mellitus type II, and Parkinson's disease based on presumptive service connection due to herbicide exposure.

The Board granted service connection for diabetes mellitus, coronary artery disease (CAD), and Parkinson's disease based on herbicide exposure during the Veteran's service.

The Board remands the claims for service connection for an eye condition, hearing loss, heart disease, arthritis, and diabetes due to a regulatory duty to assist error.

The Board granted service connection for valvular heart disease with sinus arrhythmia, which is related to the Veteran's service-connected hypertension.

The Board denied the claim for service connection for bilateral pes planus, finding that it preexisted service and did not increase in disability. The claims for ischemic heart disease, diabetes mellitus, peripheral neuropathy, hypertension, and pes planus were remanded for further development.

The Board remands the case for further development to verify the Veteran's claimed herbicide exposure while stationed in Korea from September 1967 to October 1968.

The Board granted service connection for the cause of death, determining that it is at least as likely as not that the Veteran's fatal conditions were caused by his military service.

The Board granted earlier effective dates of March 26, 2012 for service connection for coronary artery disease and associated scars post quadruple bypass.

The Board denied the veteran's claim for service connection for coronary artery disease, finding that the evidence of record failed to show that his disability began during or was otherwise caused by his active duty military service.

The Board granted service connection for arteriosclerotic heart disease, finding that the evidence is within approximate balance that it was caused by toxic exposure during service in Southwest Asia.

The Board granted service connection for atherosclerotic cardiovascular disease, arteriosclerotic heart disease with an effective date of May 28, 2023, and also granted service connection for color blindness.